ConwayBLZeydanBUygunogluUet al. Age is a critical determinant in recovery from multiple sclerosis relapses. Mult Scler. Epub ahead of print 10 October 2018. DOI: 10.1177/1352458518800815.
2.
CadavidDBalcerLGalettaSet al. Predictors of response to opicinumab in acute optic neuritis. Ann Clin Transl Neurol2018; 5(10): 1154–1162.
3.
WestlyeLTWalhovdKBDaleAMet al. Life-span changes of the human brain white matter: Diffusion tensor imaging (DTI) and volumetry. Cereb Cortex2010; 20(9): 2055–2068.
4.
FrischerJMWeigandSDGuoYet al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol2015; 78(5): 710–721.
5.
TutuncuMTangJZeidNAet al. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler2013; 19(2): 188–198.
6.
KantarciOHLebrunCSivaAet al. Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol2016; 79(2): 288–294.
7.
NovotnaMPaz SoldanMMAbou ZeidNet al. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology2015; 85(8): 722–729.
8.
WeidemanAMTapia-MaltosMAJohnsonKet al. Meta-analysis of the age-dependent efficacy of multiple sclerosis treatments. Front Neurol2017; 8: 577.
9.
AzevedoCJOvertonEKhadkaSet al. Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm2015; 2(3): e102.
10.
ZeydanBGuXAtkinsonEJet al. Cervical spinal cord atrophy: An early marker of progressive MS onset. Neurol Neuroimmunol Neuroinflamm2018; 5(2): e435.
11.
ScalfariA. MS progression is predominantly driven by age-related mechanisms – YES. Mult Scler2019; 25(7): 902–904.
12.
McGinleyMOntanedaD. MS progression is predominantly driven by age-related mechanisms – NO. Mult Scler2019; 25(7): 904–906.
